Home / Products / Cancer (Tumor) Cell Lines / NCI-H660
NCI-H660
Datasheet Protocol

NCI-H660

Cat. No. ARC0649
Product Type:

Cancer (Tumor) Cell Lines

Species:

Homo sapiens (Human)

Tissue Source:

Prostate

Growth Properties:

Suspension with some attached

In stock
$1,850.00 / Vial
Ask a Question

Short Description 🔒

NCI-H660 is a cancer cell line of prostate small cell carcinoma, isolated from metastatic; lymph node.

Recommended Products

CTSF Knockout NCI-H1975 Polyclonal Cells CTSF Knockout NCI-H1975 Polyclonal Cells Cat. No. ARG16496 ATF1 Knockout 786-O Polyclonal Cells ATF1 Knockout 786-O Polyclonal Cells Cat. No. ARG25015 ACAP2 Knockout HT29 Polyclonal Cells ACAP2 Knockout HT29 Polyclonal Cells Cat. No. ARG32826 KANK2 Knockout A549 Polyclonal Cells KANK2 Knockout A549 Polyclonal Cells Cat. No. ARG34448 DNTTIP1 Knockout 786-O Polyclonal Cells DNTTIP1 Knockout 786-O Polyclonal Cells Cat. No. ARG39515 NISCH Knockout AGS Polyclonal Cells NISCH Knockout AGS Polyclonal Cells Cat. No. ARG3223
Product Details
Cell Engineering
Immortalization
Culture Conditions
Quality Control
Disclaimer

Product Details

Product Type:
Cancer (Tumor) Cell Lines
Species:
Homo sapiens (Human)
Tissue Source:
Prostate
Disease:
Small cell carcinoma
Morphology:
Epithelial-like
Growth Mode:
Suspension with some attached
Age:
63 years
Derived From Site:
Metastatic; Lymph node
Size/Quantity:
1 million
Shipping info:
Cryopreserved in vials and shipped on dry ice

Cell Engineering Information

No cell engineering information available.

Immortalization Information

No immortalization information available.

Culture Conditions

Temperature:
37°C
Atmosphere:
5% CO₂

Quality Control

Mycoplasma testing:
Negative for mycoplasma through PCR analysis
Sterility testing:
Daily monitoring confirms that the cells are free from bacterial, yeast, and fungal contamination.
Pathogens:
Cells tested negative for HIV-1, HBV, and HCV.

Disclaimer

Intended Use:
This product is intended for laboratory in vitro use only. It is not intended for diagnostic, therapeutic, or clinical applications.
Disclaimer:
Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability.
Usage:
By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use. This product is provided "AS IS".

Description 🔒

Complete description is available upon request.

Related Products You May Also Like

FHL2 Knockout Hela Polyclonal Cells

FHL2 Knockout Hela Polyclonal Cells

Cat. No. ARG8884
 CYB5D2 Knockout Hela Polyclonal Cells

CYB5D2 Knockout Hela Polyclonal Cells

Cat. No. ARG7984
 KCTD3 Knockout K562 Polyclonal Cells

KCTD3 Knockout K562 Polyclonal Cells

Cat. No. ARG20749
 AHCYL2 Knockout HEK293T Polyclonal Cells

AHCYL2 Knockout HEK293T Polyclonal Cells

Cat. No. ARG25633
 FYN Knockout HCT116 Polyclonal Cells

FYN Knockout HCT116 Polyclonal Cells

Cat. No. ARG7305
 NUDT19 Knockout MES-OV Polyclonal Cells

NUDT19 Knockout MES-OV Polyclonal Cells

Cat. No. ARG5800